ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
TheAnalyst007
|
14K |
5.1M |
24 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
14K
|
5.1M
|
24
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
13 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
13
|
|
ASX - By Stock
|
CUV |
Re:
Taco shop worth more than Clinuvel
|
|
TheAnalyst007
|
33 |
13K |
2 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
33
|
13K
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Taco shop worth more than Clinuvel
|
|
TheAnalyst007
|
33 |
13K |
1 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
33
|
13K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
DRO at AU$2.01. Anyone taking profits?
|
|
TheAnalyst007
|
105 |
54K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
105
|
54K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
11 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
11
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
21 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
21
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
TheAnalyst007
|
554 |
201K |
8 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
554
|
201K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
TheAnalyst007
|
554 |
201K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
554
|
201K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
8 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
3
|
|
ASX - Day Trading
|
|
Re:
Morning Trading July 12
|
|
TheAnalyst007
|
324 |
49K |
1 |
12/07/24 |
12/07/24 |
ASX - Day Trading
|
324
|
49K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
TheAnalyst007
|
888 |
304K |
10 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
888
|
304K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
TheAnalyst007
|
554 |
201K |
10 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
554
|
201K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
TheAnalyst007
|
888 |
304K |
9 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
888
|
304K
|
9
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
TheAnalyst007
|
888 |
304K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
888
|
304K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
TheAnalyst007
|
554 |
201K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
554
|
201K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
TheAnalyst007
|
888 |
304K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
888
|
304K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
1 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
TheAnalyst007
|
888 |
304K |
11 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
888
|
304K
|
11
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
2 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
9 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
9
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
8 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
38
|
10K
|
3
|
|
ASX - By Stock
|
EYE |
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
TheAnalyst007
|
507 |
111K |
43 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
43
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
38
|
10K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
TheAnalyst007
|
537 |
206K |
16 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
537
|
206K
|
16
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
6 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
38
|
10K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Taco shop worth more than Clinuvel
|
|
TheAnalyst007
|
33 |
13K |
2 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
33
|
13K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
5 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
38
|
10K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Shorts are trapped
|
|
TheAnalyst007
|
69 |
27K |
5 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
69
|
27K
|
5
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: Institutional Placement
|
|
TheAnalyst007
|
81 |
30K |
8 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
81
|
30K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
38
|
10K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
5 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
38
|
10K
|
5
|
|
ASX - By Stock
|
DRO |
Re:
DroneShield (DRO) Discussion Thread
|
|
TheAnalyst007
|
564 |
245K |
9 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
564
|
245K
|
9
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
TheAnalyst007
|
38 |
10K |
9 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
38
|
10K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: CMS proposes payment improvement for radiopharma diagnostics
|
|
TheAnalyst007
|
34 |
15K |
8 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
34
|
15K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: CMS proposes payment improvement for radiopharma diagnostics
|
|
TheAnalyst007
|
34 |
15K |
25 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
34
|
15K
|
25
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: Institutional Placement
|
|
TheAnalyst007
|
81 |
30K |
9 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
81
|
30K
|
9
|
|